Navigation Links
Boehringer Ingelheim and Ashoka Changemakers Launch Competition to Find Business Models that Transform Health Systems
Date:1/24/2013

health systems," said Ashoka President Diana Wells . "We have found that in tackling health from a systems level, most of our social entrepreneurs are finding ways to 1) deliver unlikely allies to solve the healthcare practitioner shortage  or 2) are innovating new delivery systems which can reach low income populations in both urban and rural areas.  We are excited to partner with Boehringer Ingelheim once again to tap the transformative power of social entrepreneurship and to solve one of the most critical issues that is confronting society today."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing, and marketing novel products of high therapeutic value for human and veterinary medicine.

Social responsibility is a core element of Boehringer Ingelheim's culture. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of its global operations. Mutual cooperation and respect, as well as environmental protection and sustainability, are intrinsic values of all of Boehringer Ingelheim's endeavors.

For more information please visit www.boehringer-ingelheim.com

About Ashoka Changemakers

Ashoka Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social
'/>"/>

SOURCE Ashoka Changemakers
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  On May ... will convene in Santa Monica, CA ... on Lung-Sparing Therapies for Malignant Pleural Mesothelioma (MPM), ... exposure to asbestos and commonly affects the lining ... co-hosted by UCLA and the Pacific Mesothelioma Center ...
(Date:3/31/2015)... March 31, 2015 PGI has announced an ... North America at its ... The anticipated plant expansion is centered on solving the ... differentiated products for personal care product manufacturers. ... with in-line slitting and packaging, will allow customers to ...
(Date:3/31/2015)... , March 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ... developing premium quality medical marijuana products and a licensed ... Medical Purposes Regulations ( Canada ) ("MMPR"), ... from The Corporation of the District of ... the Company,s premises which now allows for commercial distribution ...
Breaking Medicine Technology:Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4PGI Expands Manufacturing Capabilities At Mexico Plant 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 Dr. Russell ... for Advanced Reconstruction. He was recently quoted in an ... caused by lymphatic issues, causing fluid retention and tissue swelling. ... procedure to relieve and / or improve lymphedema symptoms. ... improve or alleviate the symptoms of lymphedema. The goal ...
(Date:3/31/2015)... Dr. Uzma Parvez is having a busy start to ... Grounds Presentations at St. Michael’s Medical Center for attending staff ... The event was attended by a large gathering of students, ... from the Grand Rounds. It was said that it ... while. , Ahead, Dr. Parvez has been invited to ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 One of the ... be a visit to Mount Kilauea on the big island. ... few places where you can see molten lava slowly oozing at ... on earth. , One place you would never expect ... the flat, arid terrain of Mission, Texas -- until now. , ...
(Date:3/31/2015)... March 31, 2015 BESLER Consulting ... entitled, “The Value of an Independent Cost Report ... play a critical role in the determination of ... the appropriate understanding and review, this report can ... strategic planning. , This white paper discusses:, ...
(Date:3/31/2015)... WA (PRWEB) March 31, 2015 ... insurance exchange technology, has announced that Lance Hood, Senior ... HealthCare Consumerism Private Exchange Forum on April 1, 2015. ... Development of Benaissance, will address how employers can streamline ... process. , WHAT: “ Optimizing Employee and Employer ...
Breaking Medicine News(10 mins):Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3Health News:Array Health’s Senior Director of Marketing to Co-Present with Benaissance at The Institute for HealthCare Consumerism Private Exchange Forum 2
... Doheny HealthDay Reporter , THURSDAY, June 24 ... to reduce the risk of invasive breast cancer by ... a woman is considering bisphosphonate use for bone, this ... Chlebowski, a clinical oncologist at the Los Angeles Biomedical ...
... , THURSDAY, June 24 (HealthDay News) -- Ninety percent of ... government report reveals. In fact, salt is so pervasive ... consume less. Too much salt can increase your blood pressure, ... "Nine in 10 American adults consume more salt than ...
... readily and safely distinguished the brains of Alzheimer,s disease ... the doors to making such imaging available beyond facilities ... reported by a Johns Hopkins team in the June ... better ways to distinguish Alzheimer,s from other types of ...
... at Erasmus MC University Medical Centre in The Netherlands ... for the development of de novo cancer in liver ... of Liver Transplantation , a journal published by ... Study of Liver Diseases (AASLD). The 1-year survival ...
... Previous studies have shown that antiviral treatment reduces the ... hepatitis B (CHB). But now, researchers from the Division ... reporting that the antiviral therapy also prevents recurrence of ... of care for patients with HCC is local ablation ...
... NEW YORK (June 24, 2010) A team of ... developed a method to predict post-stroke recovery of language ... to predict recovery has important implications for stroke survivors ... long-term treatment needs. Findings are reported online in the ...
Cached Medicine News:Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 3Health News:Most Americans Get Too Much Salt 2Health News:Most Americans Get Too Much Salt 3Health News:Novel radiotracer shines new light on the brains of Alzheimer's disease patients 2Health News:Higher cancer rates found in liver transplant patients receiving cyclosporine for immunosuppression 2Health News:Higher cancer rates found in liver transplant patients receiving cyclosporine for immunosuppression 3Health News:Silencing hepatitis B virus prevent recurrence of liver cancer 2Health News:New metric predicts language recovery following stroke 2
Inquire...
... the elegant and sophisticated woman, ... includes ophthalmic and sunwear styles. ... variety of shapes and colors, ... shapes and complexions. Many styles ...
... updated styling through the use of innovative ... collection is for the value driven consumer ... Eyewear Collection , The futuristic quality ... of the "strongest and lightest metal on ...
Inquire...
Medicine Products: